Zurich, Switzerland

Ulf Petrausch



 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ulf Petrausch: Pioneering Innovations in Cancer Treatment

Introduction

Ulf Petrausch is an inventive mind based in Zurich, Switzerland, known for his contributions to the field of immunotherapy and cancer treatment. With a keen focus on innovative solutions, he has secured two patents that address critical challenges in the fight against cancer.

Latest Patents

Ulf's latest patents include groundbreaking methods involving HLA-B27 and HLA-B57 Fc open conformers. The first patent, titled "Use of HLA-B27 Homodimers for Cancer Treatment," introduces an HLA-B27 Fc open conformer or fusion protein designed for cancer therapy. This invention incorporates a first and second monomer, each consisting of an HLA-B27 chain, and is enhanced with a stabilizing polypeptide sequence, potentially using an amino acid linker. Further, it highlights the development of combination medicaments featuring immune checkpoint inhibitors that may enhance treatment efficacy.

His second patent, "Method of Treating Cancer with an HLA-B57 Open Conformer," presents a similar approach utilizing an HLA-B57 Fc open conformer for cancer treatment and prevention. This innovation also emphasizes combination therapies with immune checkpoint inhibitors or checkpoint agonist agents. Additionally, it explores the potential of the HLA-B57 open conformer as an immunomodulator, particularly benefiting therapeutic strategies for infectious diseases.

Career Highlights

Throughout his career, Ulf has made significant strides in research and innovation, particularly during his tenure at esteemed institutions such as Universität Zürich and Universität Basel. His expertise in the field has led to meaningful advancements in cancer treatment modalities, showcasing his commitment to improving patient outcomes.

Collaborations

Ulf has collaborated with notable professionals, including Osiris Marroquin Belaunzaran and Christoph Renner. Together, they have worked on developing cutting-edge solutions in immunotherapy, emphasizing the importance of teamwork in scientific advancement.

Conclusion

Ulf Petrausch stands out as a prominent inventor dedicated to combating cancer through innovative research. His patents showcase his commitment to advancing medical science, and his collaborations highlight the vital role of teamwork in achieving significant breakthroughs. With his continued efforts, Ulf is paving the way for future advancements in the treatment of cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…